References
- Grimes DA. Intrauterine device and upper-genital tract infection. Lancet 2000; 356: 1013–19
- Recomendaciones de la Conferencia de Consenso “Actualización del manejo clínico de la anticoncepción intrauterina. Sociedad Española de Contracepción [Recommendations of the Consensus Conference “ Update of clinical management of intrauterine contraception. Spanish Society of Contraception]. Altea, Spain, 2001.
- Meirik O. Intrauterine devices – upper and lower genital tract infections. Contraception 2007; 75: S41–7
- Farley TMM, Rosenberg MJ, Rowe PJ, Chen JH, Meirik O. Intrauterine devices and pelvic inflammatory disease: an international perspective. Lancet 1992; 339: 785–8
- Sivin I, Stern J. Health during prolonged use of levonorgestrel 20 mcg/d and the Copper TCu380AG intrauterine contraceptive devices: a multicenter study. Fertil Steril 1994; 61: 70–7
- Buchan H, Villard-Mackintosh L, Vessey M, Yeates D, McPherson K. Epidemiology of pelvic inflammatory disease in parous women with special reference to intrauterine device use. Br J Obstet Gynaecol 1990; 97: 780–8
- Mohllajee AP, Curtis KM, Peterson HB. Does insertion and use of an intrauterine device increase the risk of pelvic inflammatory disease among women with sexually transmitted infections? A systematic review. Contraception 2006; 73: 145–53
- Grimes AD, Schulz K. Prophylactic antibiotics for intrauterine device insertion: a metaanalysis of the randomized controlled trials. Contraception 1999; 60: 57–63
- Faculty of Sexual & Reproductive Healthcare Clinical Guidance. Intrauterine Contraception. 2007. Available online at: www.fsrh.org.uk (accessed June 1, 2007).
- National Institute for Health and Clinical Excellence. NICE Clinical Guideline 64: prophylaxis against infective endocarditis. 2008. Available online at www.nice.org.uk/cg64 (accessed June 1, 2007).
- Ness RB, Hillier SL, Kip E, Soper DE, Stamm CA, McGregor JA, et al. Bacterial vaginosis and risk of pelvic inflammatory disease. Obstet Gynecol 2004; 104: 761–9
- Westhoff C. IUDs and colonization or infection with Actinomyces. Contraception 2007; 75: S48–50
- Castaño PM. Use of intrauterine devices and systems by HIV-infected women. Contraception 2007; 75: S51–4
- World Health Organization. Selected practice recommendations for contraceptive use, 2nd edn. 2005. Available online at http://www.who.int/reproductive-health/publications/spr_2/index.htlm (accessed October 12, 2007).